Search Results

The HemoSite® Test System is a device for in vitro diagnostic use only. The GDS® HemoSite® Test Card is intended for the quantitative determination of hemoglobin in whole blood. It is intended for use with the Stat-Site® Meter in a point-of-care setting such as a physician's office or hospital.

The HemoSite® Test System is a whole blood hemoglobin measurement device which consists of the Stat-Site® Meter (K911801), HemoSite® Test Card and {lot-specific} HemoSite® Test Module. The test employs dry reagent technology based on the azidemethemoglobin method. The blood sample is applied to one side of the HemoSite® Test Card and the color develops on the opposite side. The color produced is directly proportional to the concentration of hemoglobin in the sample and is read using light reflectance at a specific wavelength; the reflectance reading is performed and reported by the Stat-Site® meter.

The provided text describes the HemoSite® Test System, a whole blood hemoglobin measurement device. Here's an analysis of the acceptance criteria and the study performed:

1. Table of Acceptance Criteria and Reported Device Performance

Note: The document only provides these three statistical parameters from a regression analysis. It does not explicitly state pre-defined thresholds for "acceptance" for each of these metrics. The conclusion states that the results "compare acceptably with the reference methods," implying that these values were within acceptable limits for FDA clearance.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size: 151 whole blood clinical samples.
• Data Provenance: The samples were obtained at 3 independent physician's office sites. This indicates prospective data collection. The country of origin is not explicitly stated, but given the FDA submission, it is highly likely to be the United States.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Their Qualifications

The ground truth was established using a "certified reference standard." The document does not mention the number of experts, their qualifications, or their role in establishing this reference standard. It is implied that the reference standard itself is considered the expert "ground truth."

4. Adjudication Method for the Test Set

Not applicable. The ground truth was established by comparison to a "certified reference standard," not through expert adjudication of results.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

No, an MRMC comparative effectiveness study was not done. The HemoSite® Test System is a device for quantitative determination of hemoglobin, not an AI-assisted diagnostic imaging or interpretation tool that would involve human readers.

6. If a Standalone (i.e. algorithm only without human-in-the loop performance) was done

Yes, this was a standalone performance study. The HemoSite® Test System, which includes the Stat-Site® Meter, HemoSite® Test Card, and Test Module, directly provides the hemoglobin measurement. The study evaluated the performance of this system against a reference standard. There is no mention of human-in-the-loop performance being a variable in the study design.

7. The Type of Ground Truth Used

The ground truth used was a "certified reference standard" for whole blood hemoglobin determination.

8. The Sample Size for the Training Set

The document does not mention a training set. The study described is a clinical validation against a reference standard for the purpose of demonstrating substantial equivalence, not the development or training of a machine learning model.

9. How the Ground Truth for the Training Set was Established

Not applicable, as no training set is mentioned in the document.

Ask a specific question about this device

The GDS® HemoSite® Test System is a device for in vitro diagnostic use only. The GDS® HemoSite® Test Card is intended for the quantitative determination of hemoglobin in whole blood. It is intended for use with the Stat-Site® Meter.

The HemoSite® Test Cards are dry-chemistry Test Cards that contain chemicals which react and produce color when hemoglobin is present. The Stat-Site® Meter is a reflectance colorimeter that reads color intensity. A Test Module is provided with each box of Test Cards. The Test-Module contains all current calibration information for the specific lot of reagent. The Test Module and Test Cards are coded to each other, and the Stat-Site® Meter will only operate if they are properly matched. HemoSite® Test Cards are dry reagent cards based on the azidemethemoglobin method. When a drop of whole blood is applied to the top of the Test Card, hemolysis occurs, with the release of hemoglobin. Sodium nitrite converts the hemoglobin to methemoglobin. Sodium azide converts methemoglobin to azidemethemoglobin to produce a brown color that is measured at 580 nm using the Stat-Site® Meter. The Stat-Site® Meter measures the color intensity and calculates the hemoglobin concentration.

Here's an analysis of the provided text regarding the HemoSite® Test System, addressing your specific questions:

1. Table of Acceptance Criteria and Reported Device Performance

The submission does not explicitly state pre-defined "acceptance criteria" in terms of specific thresholds for the regression analysis or precision. Instead, it presents the results of a comparison study against a predicate device and concludes that the results "compare well." Based on the provided data, we can infer the performance metrics reported.

2. Sample Size Used for the Test Set and Data Provenance

• Sample Size for the Test Set: A total of 212 venous and capillary blood samples were used.
• Data Provenance: The samples were obtained internally and at three different physician's office sites. This suggests a blend of controlled laboratory and real-world point-of-care settings. The document does not specify the country of origin, but given the submission is to the FDA, it is highly probable the data is from the United States. The study appears to be prospective in nature, as it describes obtaining samples to compare the new device against a reference method.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

This type of information is not applicable to this submission. The ground truth for this device (hemoglobin concentration) is established by a quantitative measurement from a predicate laboratory instrument, not by expert interpretation.

4. Adjudication Method for the Test Set

This type of information is not applicable to this submission. Adjudication methods are typically used when subjective interpretations (e.g., image readings) require consensus among experts. Here, the comparison is direct quantitative measurement against a reference method.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

This type of study is not applicable to the HemoSite® Test System. This device is a standalone diagnostic test for hemoglobin, not an AI-assisted interpretation system for human readers.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Yes, a standalone performance evaluation was done. The HemoSite® Test System itself is the "algorithm only" in this context. Its quantitative measurements were compared against the established reference method (Coulter® JT) without human interpretation as part of the measurement process. The device's performance (regression statistics and precision) represents its standalone capability.

7. The Type of Ground Truth Used

The ground truth used was measurements from a predicate laboratory instrument: the Coulter® JT hematology analyzer. This is a form of reference standard/comparative method rather than expert consensus, pathology, or outcomes data.

8. The Sample Size for the Training Set

The document does not explicitly mention a "training set" or its sample size. This is a 1998 510(k) submission for a diagnostic device that performs a chemical reaction and colorimetry. While the device likely has internal calibration and validation processes (which could be considered analogous to "training" in a very broad sense), the submission focuses on the performance of the final device against a predicate, not on the development of a complex algorithm that requires a distinct, external training set in the modern AI sense. The "Test Module" provided with each box of Test Cards contains "all current calibration information for the specific lot of reagent," implying internal calibration data, but the size or nature of this data is not detailed as a "training set."

9. How the Ground Truth for the Training Set Was Established

Since a "training set" in the modern sense of AI/machine learning isn't explicitly described or applicable, the method for establishing its ground truth is also not applicable. The device's function relies on established chemical principles and colorimetric measurement, with calibration data likely derived from known hemoglobin standards.

Ask a specific question about this device